Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
  1. 4 Open-market sale SVP, CFO sold 11,958 shares at $0.39 ($4,652)
  2. 4 Open-market sale EVP, Global Head RA & Quality sold 3,267 shares at $0.39 ($1,271)
  3. 4 Open-market buy Director bought 270,000 shares at an average $0.25 ($68,214)
  4. 4 Open-market buy Director bought 100,000 shares at $0.25 ($25,330)
  5. 4 Open-market buy Director bought 446,825 shares at $0.23 ($101,340)
  6. 4 Open-market sale SVP, CFO sold 8,186 shares at an average $1.65 ($13,527)
  7. 4 Open-market sale EVP, Chief Legal Officer sold 8,672 shares at an average $1.65 ($14,330)
  8. 4 Open-market sale President and CEO sold 30,766 shares at an average $1.65 ($50,835)
  9. 4 Open-market sale EVP, Chief Sci. & Tech Officer sold 15,126 shares at an average $1.65 ($24,997)
  10. 4 Open-market sale EVP, Chief Medical Officer sold 6,975 shares at an average $1.65 ($11,526)
  11. 4 Open-market sale EVP, Global Head RA & Quality sold 3,346 shares at an average $1.65 ($5,531)
  12. 4 Open-market sale President and CEO sold 14,291 shares at $1.66 ($23,723)
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Director acquired 57,000 shares (grant or award)
  17. 4 Grant or award Director acquired 57,000 shares (grant or award)
  18. 4 Grant or award Director acquired 57,000 shares (grant or award)
  19. 4 Grant or award Director acquired 57,000 shares (grant or award)
  20. 4 Grant or award Director acquired 57,000 shares (grant or award)

Page 5 of 33 · 644 filings